Trial Profile
Predictors of Adverse Events after Onabotulinumtoxina Treatment for Patients with Overactive Bladder Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- 05 Nov 2015 New trial record
- 09 Oct 2015 Results presented at the 45th Annual Meeting of the International Continence Society